{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-095506","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.997921+00:00","generated_at":"2026-05-30T03:50:15.969987+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Estrella Immunopharma enters employment agreement with CEO Cheng Liu; base salary $250,000","bullets":["Base salary of $250,000 per year, plus annual cash bonus based on performance metrics set by Compensation Committee.","Severance: 6 months base salary for termination without cause or resignation for good reason; 12 months plus equity acceleration if tied to change in control.","Agreement includes non-disclosure and confidentiality covenants; effective November 1, 2024, at-will employment.","CEO retains ability to hold outside directorships and positions, subject to Board review."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-095506","json":"https://secwatch.observer/filing/0001213900-24-095506.json","markdown":"https://secwatch.observer/filing/0001213900-24-095506.md","text":"https://secwatch.observer/filing/0001213900-24-095506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024095506/0001213900-24-095506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024095506/ea0220428-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:50:15.969987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}